Clinique Ambroise Pare
Neuilly-sur-Seine 92200
2 studies enrolling now · 8 studies all time
What they study most
Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Colitis, Ulcerative, Crohn Disease, Crohn's Disease, Endometrial Cancer, Esophageal Squamous Cell Carcinoma, Fistulizing Crohns Disease, Gastric Cancer, Hepatocellular Carcinoma, Pancreatic Adenocarcinoma, Perianal Crohns Disease
Studies at this site
- JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC — Recruiting now
- A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease — Recruiting now
- A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors — Recruiting now
- A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis — Running, not enrolling
- A Study of Guselkumab in Participants With Fistulizing, Perianal Crohn's Disease — Running, not enrolling
- A Study of Guselkumab Therapy in Participants With Moderately to Severely Active Ulcerative Colitis — Running, not enrolling
- A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease — Running, not enrolling
- A Study of JNJ-77242113 in Participants With Moderately to Severely Active Ulcerative Colitis — Completed